This has been suggested by experimental findings of needle electrode measurements of human glioma [29] and by immunohistochemical studies using HIF-1α or carbonic anhydrase IX (CA IX) as an endogenous hypoxia marker [30,31] or EF5 as an injectable hypoxia marker [32]. The gene discussed is CA9; the disease is central nervous system cancer.